{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:46:56Z","timestamp":1792079216146,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00520-026-11338-x","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:04Z","timestamp":1792077304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comorbidity patterns and their associations with performance status and treatment receipt in breast and colorectal cancers in a multiethnic Asian setting: a latent class analysis"],"prefix":"10.1007","volume":"34","author":[{"given":"Yee-Yin","family":"Hoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huah Shin","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Danaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogda","family":"Koczwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivatharshini","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shridevi","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Fadhlina","family":"Abdul Satar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthukkumaran","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Har","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Bhoo-Pathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"3","key":"11338_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"11338_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.Epi-16-0133","volume":"25","author":"SM Bluethmann","year":"2016","unstructured":"Bluethmann SM, Mariotto AB, Rowland JH (2016) Anticipating the \u201csilver tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 25(7):1029\u20131036. https:\/\/doi.org\/10.1158\/1055-9965.Epi-16-0133","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"11338_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(25)00017-8","author":"EC Dee","year":"2022","unstructured":"Dee EC, Laversanne M et al (2022) Cancer incidence and mortality estimates in 2022 in Southeast Asia: a comparative analysis. Lancet Oncol. https:\/\/doi.org\/10.1016\/s1470-2045(25)00017-8","journal-title":"Lancet Oncol"},{"issue":"5","key":"11338_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101517","volume":"5","author":"N Bhoo-Pathy","year":"2024","unstructured":"Bhoo-Pathy N, Taylor C, Unger-Salda\u00f1a K (2024) Operationalizing patient-centered cancer care in low- and middle-income countries. Cell Rep Med 5(5):101517. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101517","journal-title":"Cell Rep Med"},{"issue":"9","key":"11338_CR5","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jclinepi.2012.02.017","volume":"65","author":"D Sarfati","year":"2012","unstructured":"Sarfati D (2012) Review of methods used to measure comorbidity in cancer populations: no gold standard exists. J Clin Epidemiol 65(9):924\u2013933. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.02.017","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"11338_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.13002","volume":"287","author":"FA McAlister","year":"2020","unstructured":"McAlister FA, Savu A et al (2020) The hospital frailty risk score in patients with heart failure is strongly associated with outcomes but less so with pharmacotherapy. J Intern Med 287(3):322\u2013332. https:\/\/doi.org\/10.1111\/joim.13002","journal-title":"J Intern Med"},{"issue":"1","key":"11338_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/28352610.2024.2407969","volume":"2","author":"JE Leong","year":"2024","unstructured":"Leong JE, Tan BJW et al (2024) Comparative analysis of clinical comorbidity assessment tools in cancer. Cancer Surviv Res Care 2(1):2407969. https:\/\/doi.org\/10.1080\/28352610.2024.2407969","journal-title":"Cancer Surviv Res Care"},{"key":"11338_CR8","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3332\/ecancer.2022.1512","volume":"17","author":"S Subramaniam","year":"2023","unstructured":"Subramaniam S, Kong YC et al (2023) Association between pre-existing cardiometabolic comorbidities and the pathological profiles of breast cancer at initial diagnosis: a cross sectional study. Ecancermedicalscience 17:1512. https:\/\/doi.org\/10.3332\/ecancer.2022.1512","journal-title":"Ecancermedicalscience"},{"issue":"11","key":"11338_CR9","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.31557\/apjcp.2023.24.11.3805","volume":"24","author":"T Wadasadawala","year":"2023","unstructured":"Wadasadawala T, Datta D et al (2023) Prospective study of incidence and impact of comorbidities on breast cancer survival from India. Asian Pac J Cancer Prev 24(11):3805\u20133814. https:\/\/doi.org\/10.31557\/apjcp.2023.24.11.3805","journal-title":"Asian Pac J Cancer Prev"},{"issue":"25","key":"11338_CR10","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1200\/jco.20.00721","volume":"38","author":"JM Scott","year":"2020","unstructured":"Scott JM, Stene G et al (2020) Performance status in cancer: not broken, but time for an upgrade? J Clin Oncol 38(25):2824\u20132829. https:\/\/doi.org\/10.1200\/jco.20.00721","journal-title":"J Clin Oncol"},{"issue":"4","key":"11338_CR11","doi-asserted-by":"publisher","DOI":"10.2196\/26425","volume":"7","author":"M George","year":"2021","unstructured":"George M, Smith A et al (2021) Physical comorbidities and their relationship with cancer treatment and its outcomes in older adult populations: systematic review. JMIR Cancer 7(4):e26425. https:\/\/doi.org\/10.2196\/26425","journal-title":"JMIR Cancer"},{"issue":"1","key":"11338_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10549-017-4295-4","volume":"165","author":"MJ Edwards","year":"2017","unstructured":"Edwards MJ, Campbell ID et al (2017) Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 165(1):17\u201339. https:\/\/doi.org\/10.1007\/s10549-017-4295-4","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"11338_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22904","volume":"110","author":"V Launay-Vacher","year":"2007","unstructured":"Launay-Vacher V, Oudard S et al (2007) Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer 110(6):1376\u201384. https:\/\/doi.org\/10.1002\/cncr.22904","journal-title":"Cancer"},{"issue":"15","key":"11338_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70057","volume":"13","author":"HS Ng","year":"2024","unstructured":"Ng HS, Meng R et al (2024) Cardiovascular mortality in people with cancer compared to the general population: a systematic review and meta-analysis. Cancer Med 13(15):e70057. https:\/\/doi.org\/10.1002\/cam4.70057","journal-title":"Cancer Med"},{"key":"11338_CR15","unstructured":"Bank, W. Malaysia: overview. 2025 19 November 2025]; Available from: https:\/\/www.worldbank.org\/en\/country\/malaysia\/overview."},{"issue":"1","key":"11338_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000521288","volume":"91","author":"ME Charlson","year":"2022","unstructured":"Charlson ME, Carrozzino D et al (2022) Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom 91(1):8\u201335. https:\/\/doi.org\/10.1159\/000521288","journal-title":"Psychother Psychosom"},{"issue":"9","key":"11338_CR17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.clon.2020.06.016","volume":"32","author":"R Simcock","year":"2020","unstructured":"Simcock R, Wright J (2020) Beyond performance status. Clin Oncol (R Coll Radiol) 32(9):553\u2013561. https:\/\/doi.org\/10.1016\/j.clon.2020.06.016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"11338_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/jgo.18.00214","volume":"5","author":"A Costas-Chavarri","year":"2019","unstructured":"Costas-Chavarri A, Nandakumar G et al (2019) Treatment of patients with early-stage colorectal cancer: ASCO resource-stratified guideline. J Glob Oncol 5:1\u201319. https:\/\/doi.org\/10.1200\/jgo.18.00214","journal-title":"J Glob Oncol"},{"issue":"5","key":"11338_CR19","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.breast.2014.08.009","volume":"23","author":"F Cardoso","year":"2014","unstructured":"Cardoso F, Costa A et al (2014) ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast 23(5):489\u2013502. https:\/\/doi.org\/10.1016\/j.breast.2014.08.009","journal-title":"Breast"},{"key":"11338_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2024.103756","volume":"76","author":"F Cardoso","year":"2024","unstructured":"Cardoso F, Paluch-Shimon S et al (2024) 6th and 7th international consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7). Breast 76:103756. https:\/\/doi.org\/10.1016\/j.breast.2024.103756","journal-title":"Breast"},{"issue":"1","key":"11338_CR21","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/ccm.0000000000004710","volume":"49","author":"P Sinha","year":"2021","unstructured":"Sinha P, Calfee CS, Delucchi KL (2021) Practitioner\u2019s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med 49(1):e63\u2013e79. https:\/\/doi.org\/10.1097\/ccm.0000000000004710","journal-title":"Crit Care Med"},{"issue":"9","key":"11338_CR22","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1016\/j.jid.2020.05.079","volume":"140","author":"L Naldi","year":"2020","unstructured":"Naldi L, Cazzaniga S (2020) Research techniques made simple: latent class analysis. J Invest Dermatol 140(9):1676-1680.e1. https:\/\/doi.org\/10.1016\/j.jid.2020.05.079","journal-title":"J Invest Dermatol"},{"issue":"1","key":"11338_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2454330","volume":"57","author":"HS Ng","year":"2025","unstructured":"Ng HS, Woodman R et al (2025) Comorbidity patterns and mortality in atrial fibrillation: a latent class analysis of the EURopean study of older subjects with atrial fibrillation (EUROSAF). Ann Med 57(1):2454330. https:\/\/doi.org\/10.1080\/07853890.2025.2454330","journal-title":"Ann Med"},{"issue":"2","key":"11338_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/aje\/155.2.176","volume":"155","author":"MA Hern\u00e1n","year":"2002","unstructured":"Hern\u00e1n MA, Hern\u00e1ndez-D\u00edaz S et al (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155(2):176\u2013184. https:\/\/doi.org\/10.1093\/aje\/155.2.176","journal-title":"Am J Epidemiol"},{"key":"11338_CR25","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3332\/ecancer.2019.913","volume":"13","author":"SS Datta","year":"2019","unstructured":"Datta SS, Ghosal N et al (2019) How do clinicians rate patient\u2019s performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology. ecancermedsci 13:913. https:\/\/doi.org\/10.3332\/ecancer.2019.913","journal-title":"ecancermedsci"},{"key":"11338_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103161","volume":"82","author":"G Sandhu","year":"2025","unstructured":"Sandhu G, Adattini J et al (2025) Integrating international consensus guidelines for anticancer drug dosing in kidney dysfunction (ADDIKD) into everyday practice. eClinicalMedicine 82:103161. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103161","journal-title":"eClinicalMedicine"},{"issue":"2","key":"11338_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12282-023-01530-w","volume":"31","author":"YW Hong","year":"2024","unstructured":"Hong YW, Kuo IM et al (2024) The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience. Breast Cancer (Auckl) 31(2):252\u2013262. https:\/\/doi.org\/10.1007\/s12282-023-01530-w","journal-title":"Breast Cancer (Auckl)"},{"issue":"20","key":"11338_CR28","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/cir.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J et al (2023) Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148(20):1606\u20131635. https:\/\/doi.org\/10.1161\/cir.0000000000001184","journal-title":"Circulation"},{"issue":"5","key":"11338_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeaf115","volume":"5","author":"T Ko","year":"2025","unstructured":"Ko T, Suzuki Y et al (2025) Cardiovascular-kidney-metabolic syndrome stage predicts cardiovascular outcomes in cancer patients: a real-world data analysis of a nationwide epidemiological dataset. Eur Heart J Open 5(5):oeaf115. https:\/\/doi.org\/10.1093\/ehjopen\/oeaf115","journal-title":"Eur Heart J Open"},{"key":"11338_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71562","author":"H Yang","year":"2022","unstructured":"Yang H, Bhoo-Pathy N et al (2022) Risk of heart disease following treatment for breast cancer - results from a population-based cohort study. Elife. https:\/\/doi.org\/10.7554\/eLife.71562","journal-title":"Elife"},{"key":"11338_CR31","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2021.1293","volume":"15","author":"S Subramaniam","year":"2021","unstructured":"Subramaniam S, Kong YC et al (2021) Baseline cardiovascular comorbidities, and the influence on cancer treatment decision-making in women with breast cancer. Ecancermedicalscience 15:1293. https:\/\/doi.org\/10.3332\/ecancer.2021.1293","journal-title":"Ecancermedicalscience"},{"issue":"41","key":"11338_CR32","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T et al (2022) 2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J 43(41):4229\u20134361. https:\/\/doi.org\/10.1093\/eurheartj\/ehac244","journal-title":"Eur Heart J"},{"issue":"4","key":"11338_CR33","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/eurjpc\/zwaf711","volume":"33","author":"YW Cai","year":"2026","unstructured":"Cai YW, Gao JW et al (2026) Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study. Eur J Prev Cardiol 33(4):578\u2013586. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf711","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"11338_CR34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/ehf2.12838","volume":"7","author":"A Alizadehasl","year":"2020","unstructured":"Alizadehasl A, Amin A et al (2020) Cardio-oncology discipline: focus on the necessities in developing countries. ESC Heart Fail 7(5):2175\u20132183. https:\/\/doi.org\/10.1002\/ehf2.12838","journal-title":"ESC Heart Fail"},{"issue":"1","key":"11338_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0338721","volume":"21","author":"TT Pham","year":"2026","unstructured":"Pham TT, Connor AE, Rositch AF (2026) Multimorbidity and cancer treatment among the older patients in the United States. PLoS ONE 21(1):e0338721. https:\/\/doi.org\/10.1371\/journal.pone.0338721","journal-title":"PLoS ONE"},{"key":"11338_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2147\/ijgm.S435001","volume":"17","author":"A Smith","year":"2024","unstructured":"Smith A, Boby JM et al (2024) Immunotherapy in older patients with cancer: a narrative review. Int J Gen Med 17:305\u2013313. https:\/\/doi.org\/10.2147\/ijgm.S435001","journal-title":"Int J Gen Med"},{"issue":"21","key":"11338_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3238\/arztebl.2011.0365","volume":"108","author":"ML Sautter-Bihl","year":"2011","unstructured":"Sautter-Bihl ML, Souchon R, Gerber B (2011) Adjuvant therapy for women over age 65 with breast cancer. Dtsch Arztebl Int 108(21):365\u2013371. https:\/\/doi.org\/10.3238\/arztebl.2011.0365","journal-title":"Dtsch Arztebl Int"},{"key":"11338_CR38","doi-asserted-by":"publisher","DOI":"10.1200\/go.24.00054","volume":"10","author":"S Jaya-Prakason","year":"2024","unstructured":"Jaya-Prakason S, Kong Y-C et al (2024) Trends in presentation, management, and survival of women with breast cancer in a multiethnic, middle-income Asian setting. JCO Glob Oncol 10:e2400054. https:\/\/doi.org\/10.1200\/go.24.00054","journal-title":"JCO Glob Oncol"},{"issue":"8","key":"11338_CR39","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/s41416-024-02838-w","volume":"131","author":"A Abravan","year":"2024","unstructured":"Abravan A, Faivre-Finn C et al (2024) Comorbidity in patients with cancer treated at The Christie. Br J Cancer 131(8):1279\u20131289. https:\/\/doi.org\/10.1038\/s41416-024-02838-w","journal-title":"Br J Cancer"},{"issue":"2","key":"11338_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/nnr.0000000000000332","volume":"68","author":"S Jeon","year":"2019","unstructured":"Jeon S, Sikorskii A et al (2019) Latent transition analysis of the symptom experience of cancer patients undergoing chemotherapy. Nurs Res 68(2):91\u201398. https:\/\/doi.org\/10.1097\/nnr.0000000000000332","journal-title":"Nurs Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11338-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11338-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:07Z","timestamp":1792077307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11338-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["11338"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11338-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"National Medical Research Registry and Medical Research and Ethics Committee (NMRR ID 21-1757-60381(IIR); NMRR-21-1758-61030(IIR); NMRR-21-1153-58621(IIR)), University of Malaya Research Ethics Committee (20181016\u20106757, 202183\u201310444, 2021722-10405), SJMC (202112.01, 202203.2, 202204.1), KPJ (kpj_004\/2002), PHKL (PHKL-EC-2022-0002, PHKL-EC-2022-0004).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yee-Yin Hoo, Mahmoud Danaee, Shridevi Subramaniam have no competing interests to declare that are relevant to the content of this article. Huah Shin Ng has received research funding from the Cancer Council South Australia Early Career Research Fellowship. Bogda Koczwara has received advisory fees from Cancer Australia and Movember and speaker honoraria from The Limbic, and is supported by the Australian Research Centre for Cancer Survivorship, a partnership between Cancer Council NSW and UNSW Sydney.. Siva Tharshini Ramalingam has received advisory fees and speaker honoraria from Astra Zeneca, Ferring, Novartis, Accord and Pfizer. Nur Fadhlina Abdul Satar has received advisory fees, research grants, educational sponsorship from Naluri Hidup, KURA oncology, MSD, Viracta therapeutics, Zuellig Pharma, Novartis, Pfizer and Astra Zeneca, Gene Solutions, Merck, AbexMedical. Muthukkumaran Thiagarajan has received advisory fees from Astella, Janssen, MSD and Roche. Cheng Har Yip has received advisory fees from Astra Zeneca. Nirmala Bhoo-Pathy has received consultancy fees and investigator-initiated research grants from Eisai, Novartis, Takeda, Pharmaceutical Association of Malaysia, City Cancer Challenge and the National Cancer Council (MAKNA).","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT to rephrase the content to improve readability and language of the manuscript. After using these tools, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":4,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1106"}}